Live Deals
Active Portfolio
Enabling precision genetic medicine
2019 Seed+
2017 Seed
2017 Seed
- Universal delivery platform for gene therapies
- Rapid, affordable, targeted to specific cell types
- Disrupting $100B+ Hematology Market
Changing the way cancer is treated
Seed
Series A
Pre-B
Series B
Series A
Pre-B
Series B
- Platform identifies personalized drug combinations
- Highly accurate drug response predictions
- Multiple academic/pharma partnerships underway
Helping global populations live chronic disease-free
2018 Seed
- Digital diabetes prevention 2X effective as drugs
- Reducing risk of Type-2 Diabetes by 60%
- International partnership with Merck KGaA
Crowdsourcing medical expertise
2016 Seed
- Solving elusive cases (avg: 6+ years, 8+ doctors)
- 1M+ unique monthly visitors
- 5-18X ROI for doctors/health plans/employers
Revolutionizing the way the world views science
2017 Series A
2016 Seed
2016 Seed
- World’s first hybrid microscope
- Easy-to-use, stunning digital display
- 8X increase in researcher productivity
Early Diagnosis and Treatment of Alzheimer's Without Drugs
2019 Seed
- 250M Alzheimer's Patients thru 2050 = $5.4T Market
- AD Drugs Failing in Humans; Only Treating Symptoms
- Predict AD Risk, Prevent & Treat Underlying Cause
Wireless Electronics to Stimulate Surgical Healing of Bone
Seed
- Stimulate/Adjust/Monitor Bone Growth in Real Time
- Tackling an Annual $80B Problem in Orthopedics
- SmartFuse: Heals Bone 4X Better, 2X Faster, Safer
BV Showcase
Mining the microbiome for novel therapeutic molecules
- Computational drug discovery from within the body
- Vast Data Engine: 10k patient samples, 38TB data
- 2 Paid industry clients, 7 partner clinical orgs
Next-generation 3D bioprinting platform
- Proprietary, light-based 3D bioprinting
- 10x Speed and 5x Resolution
- Most advanced engineered tissue ever
Revolutionizing preclinical drug discovery research
- 50% cost reductions, 70% efficiency improvements
- Tier 1 paid clients: Novartis, Denali, Jackson Lab
- Vetted, Awarded $1.85M in funding from NIH
The Bioverge platform is host to both Regulation Crowdfunding and Regulation D offering types. Reg CF offerings are provided by Bioverge Portal LLC and Reg D offering are provided by Bioverge Funds Management LLC. Companies designated as BV Showcase are enrolled in a program managed by Bioverge Inc and are not associated with an offering on the Bioverge platform.
